Arthritis, Musculoskeletal and Skin Diseases Research in Texas
Arthritis, Musculoskeletal and Skin Diseases Research (93.846) awarded $87.3 million to recipients in Texas in 103 grants from fiscal 2021 to 2025, 3.3% of the program's national total. The University of Texas Southwestern Medical Center received the most, $25.4 million.
- Awarded in Texas$87.3 million
- Awards103
- Share of the program3.3%
- Rank among states8th of 44
- National total$2.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 51 | $18.7 million |
| FY 2022 | 40 | $14.8 million |
| FY 2023 | 53 | $19.5 million |
| FY 2024 | 51 | $18.0 million |
| FY 2025 | 48 | $16.4 million |
Recipients in Texas
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The University of Texas Southwestern Medical Center | Colleges and universities | 30 | $25.4 million |
| Baylor College of Medicine | Colleges and universities | 24 | $23.6 million |
| University of Texas Health Science Center at Houston | Colleges and universities | 17 | $14.1 million |
| University of Houston System | Colleges and universities | 8 | $6.8 million |
| The University of Texas Health Science Center at San Antonio | Colleges and universities | 3 | $2.6 million |
| Texas a & M University System Health Science Center | Colleges and universities | 4 | $2.5 million |
| University of Texas at Austin | Colleges and universities | 3 | $2.4 million |
| Texas A&m Engineering Experiment Station | Colleges and universities | 2 | $1.8 million |
| Nanohmics Inc | Small businesses | 1 | $1.7 million |
| The University of Texas at San Antonio | Colleges and universities | 1 | $1.4 million |
Open opportunities under this program
- Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
- Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
- HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed)
- NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
See all 62 on the program page
Questions people ask
How much Arthritis, Musculoskeletal and Skin Diseases Research money goes to Texas?
$87.3 million from fiscal 2021 to 2025, across 103 awards. Texas ranks 8th of 44 states and territories for this program.
Who receives Arthritis, Musculoskeletal and Skin Diseases Research money in Texas?
The largest recipient is The University of Texas Southwestern Medical Center, with $25.4 million in 30 awards. Next are Baylor College of Medicine and University of Texas Health Science Center at Houston.
Can organizations in Texas apply now?
Yes, 62 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Arthritis, Musculoskeletal and Skin Diseases Research in other states
Other large programs in Texas
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Child Care and Development Block Grant
- Title I Grants to Local Educational Agencies
- Unaccompanied Alien Children Program
- Special Education Grants to States
- Community Development Block Grants/State's program and Non-Entitlement Grants in Hawaii